Skip to main content
Earnings Labs
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ·Healthcare·Biotechnology

$17.26

+0.00%

Mkt Cap $2.24B

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (10 analysts)

$16.00

Range $16.00 – $16.00

Implied Upside

-7.3%

Consensus $16.00 vs current $17.26